Shine Corporate (SHJ)
Shine Corporate Ltd. operates as a holding company, which engages in the damages based plaintiff litigation legal services. It operates though two segments: Personal Injury and Emerging Practice Areas. The Personal Injury segment engages in the damaged based plaintiff litigation and also provides medical negligence, public liability, catastrophic injuries, workers compensation, and motor vehicle accidents. The Emerging Practice Areas segment engages in the disability insurance and superannuation claims, professional negligence, social justice, class actions, first party insurance recovery claims, landowners rights, aviation, product liability, family law and asbestos compensation. The company was founded by Simon Morrison and Stephen Francis Roche in 1976 and is headquartered in Brisbane, Australia.
|Market Price at 08-12-2017
|Price to Earnings Ratio
|Return on Equity (ROE)
Blog posts that reference Shine Corporate:
Thursday, July 07, 2016
Sirtex Medical is a biotechnology stock that is focused on developing solutions to treat people with liver cancer. With a market capitalisation of $1.5 billion, it is considered a small-cap stock but it is by no means tiny. Unlike many biotech companies, Sirtex is already a very profitable company. In 2015 it generated a profit of $40 million, which represented growth of 70% on the previous year.
Friday, January 29, 2016
On 18 January Shine Corporation (SHJ) announced that they were expecting a material reduction in forecast earnings as a result of a review of their cash flow assumptions. The stock was suspended pending the outcome of this review.
This experience highlights the importance of using the Skaffold Cashflow evaluation screen to cross check just how robust the reported profits really are. Shine has consistently shown operating cash flow of less than 40 per cent of profits and produced a funding gap every year.
Thursday, October 23, 2014
Shine Corporate, (CODE:SHJ) the third largest plaintiff litigation firm has reaffirmed its August 27, 2014 guidance. Addressing shareholders on Wednesday (October 22, 2014) the chairman was upbeat indicating there were acquisition prospects in the pipeline. Management also confirmed the previously estimated negative net profit impact of between $2 million and $2.5 million in relation to Queensland WorkCover changes.
Thursday, June 12, 2014
This morning recently-listed (May 2013) legal services firm Shine Corporate (SHJ) announced an entitlement offer seeking to raise $30 million.
SHJ is a micro cap stock, so it’s not everyone’s cup of tea. That probably explains why it’s only on the radar of a handful of Skaffold members.
Four Skaffold members ‘Like’, and three ‘Dislike’ SHJ. If you hold the stock, what’s your view of their latest strategic move? Will you participate in the entitlement offer?
Thursday, March 06, 2014
IPOs have the potential to give your portfolio entry-level access to quality stocks well positioned for a profitable future.
Unfortunately the share market has no shortage of IPOs that bombed, and relatively recent newcomers like Collins Foods and Myer have both struggled to trade above their float price. If Boart Longyear is any proxy, there’s no guarantee these stocks will rally any time soon. Since floating in 2007 BLY’s share price has fallen more than 97%.
So don’t get sucked into buying overpriced and overspruiked companies wired to uninspiring sectors with questionable growth projections destined to lose you money.
Friday, November 22, 2013
Chris Batchelor, general manager of stock research application provider Skaffold, reckons you can find quality outside Australia's blue-chip companies.
"The focus for us is not on blue chips but on top-quality businesses," Batchelor says.
Batchelor uses a range of measures in order to determine what makes a good company. The obvious measures include cash flow, return on equity, debt-to-equity ratios and earnings per share (EPS).
Cash flow is also another important metric that should not be used in isolation.
"The cash flow ratio compares the amount of cash a business generates to its profit. You would expect the two to relate, but sometimes they diverge and it is important to understand why," Batchelor says.
Saturday, November 02, 2013
Top stocks have five things in common: great management, impressive return on equity, low debt, strong earnings per share growth and positive intrinsic value growth.
Right now in Skaffold there are a handful of stocks that exhibit these characteristics. We first wrote about them at our blog on 22 October. Click here to read about these businesses and see their key performance ratios.
At our webinar, How to identify investment opportunities in an overpriced market, Skaffold’s General Manager Chris Batchelor CFA shared his insights on the opportunities and potential challenges for a handful of these businesses. Here are Chris’s insights.
Tuesday, October 22, 2013
We’ve trawled Skaffold to find a handful of top stocks that offer hidden value in an overpriced market.
Encompassing motion pictures and tv production, scientific instruments, energy auction procurement, retail, technology, and business, engineering and legal services, the 10 businesses uncovered in Skaffold have a demonstrated track record of improving performance, and for the majority, are trading at a discount to Skaffold’s current intrinsic value estimate.
Exclusively for Skaffold members, here’s a sneak peek of the stocks we discussed at our webinar titlede "How to find opportunities in an overpriced market". We've also included a brief discussion on why we believe these companies represent the best opportunities in a market that has rallied well beyond Skaffold’s intrinsic valuations for the majority of Australia’s Top 200 stocks.